- Framework of problems / Rigourous
- Risk of bias not incorporated into conclusions of review
- Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension
Ref ID | 941 |
First Author | R. Kanukula |
Journal | BMJ EVIDENCE-BASED MEDICINE |
Year Of Publishing | 2022 |
URL | https://ebm.bmj.com/content/27/2/79.long |
Keywords |
Cardiology Low reporting quality Non-Cochrane reviews Low methodological quality |
Problem(s) |
Reasons for excluding potentially eligible studies not provided Risk of bias not incorporated into conclusions of review Low reporting (PRISMA) quality Low methodological (AMSTAR) quality No registered or published protocol |
Number of systematic reviews included | 40 |
Summary of Findings | From 40 included systematic reviews that informed recommendations in the recent American and European hypertension guidelines published up to 2018. Methodological (AMSTAR 2) and reporting (PRISMA) quality were found to vary considerably. Lack of information on the funding source of included studies, use of a protocol, integration of risk of bias assessments while interpreting findings and reporting of excluded studies were major methodological deficiencies. |
Did the article find that the problem(s) led to qualitative changes in interpretation of the results? | Not Applicable |
Are the methods of the article described in enough detail to replicate the study? | Yes |